HKSE:2575
Xuanzhubio-b · HKSE · Healthcare · HKD · FY for 2025
Figures on this page computed 2026-11-08 13:25 UTC
Last close
n/aHKD
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-474.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
-398.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.0005Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Price is the furthest below its sector's middle: 0.18 against 0.38 on the market's range.
- Growth55.9%76 of 100, above its sector
- Returns on capital-17.4%28 of 100, above its sector
- Margins38.8%19 of 100, below its sector
- Price2.8x18 of 100, below its sector
- Safety0.000586 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Then and now
lens 3 of 9| Fact | 2019 | 2025 | Change |
|---|---|---|---|
| Sales | n/a | 56,147,943 | n/a |
| Profit | -404,804,302 | -266,260,248 | +34.2% |
| Free cash flow | -542,967,499 | -223,595,100 | +58.8% |
| Debt | 10,831,162 | 720,637 | -93.4% |
| Shares in issue | n/a | 517,947,790 | n/a |
The same five facts for 2019 and 2025, each read from the year's own filing.
The same five facts for 2019 and 2025, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2019
Sales, 2019n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- HKD
Sales, 202556,147,943Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
Profit, 2019-404,804,302
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- HKD
Profit, 2025-266,260,248Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
Free cash flow, 2019-542,967,499
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- HKD
Free cash flow, 2025-223,595,100Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
Debt, 201910,831,162
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- HKD
Debt, 2025720,637Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD
Shares in issue, 2019n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- HKD
Shares in issue, 2025517,947,790Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- HKD